Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Comparison of outcomes in pediatric patients with acute leukemia undergoing allogeneic HLA-haploidentical hematopoietic stem cell transplantation (HSCT) after in vitro a/b T- and CD19-cell depletion or In Vivo administration of post-transplant cyclophosphamide: An EBMT pediatric working party study

Blood (2025) 146 (Supplement 1): 515.

https://doi.org/10.1182/blood-2025-515

Published: 2025

Journal Articles

Haploidentical donor regulatory T cells and memory T cells are safe and effective in children with refractory graft-versus-host disease with concurrent viral infections

VictoryIa Vedmedskaia, Dmitriy Pershin, Larisa Shelikhova, Evelina Lyudovskih, Yulia Skvortsova, Maria Fadeeva, Ekaterina Malakhova, Tatiana Sozonova, Elena Kulakovskaya, Oyuna Lodoeva, Elvira Musaeva, Daria Osipova, Elena Osipova, Alexei Kazachenok, Vladislav Belchikov, Anastasia Melkova, Dmitriy Balashov, Michael Maschan

Blood (2025) 146 (Supplement 1): 6013.

https://doi.org/10.1182/blood-2025-6013

Published: 2025

Journal Articles

Significance of CD229 expression assessment for detection of minimal residual disease in patients with multiple myeloma.

Darya Kisilichina, Iuliia Oleinik, Victoria Skurikhina, Arina Lugovaya, Vera Zherebtsova, Lev Butaev, Anna Otmorsckaya, Michael Maschan, Vadim Ptushkin

Blood (2025) 146 (Supplement 1): 3991.

https://doi.org/10.1182/blood-2025-3991

Published: 2025

Journal Articles

Targeted GvHD prophylaxis: Vedolizumab in the GvHD prevention regime with post-transplant cyclophophospamide, abatacept, calceneurin inhibitors in adults with hematologic disease: Result prospective study

Artur Yunusov, Iuliia Oleinik, Anton Subora, Irina Zikunova, Victoria Skurikhina, Sergey Shalaev, Matvei Bulusov, Evdokia Urnova, Michael Maschan, Vadim Ptushkin

Blood (2025) 146 (Supplement 1): 7755.

https://doi.org/10.1182/blood-2025-7755

Published: 2025

Journal Articles

Donor-derived CAR-T cells co-infused with the allogenic graft on the platform of T cell depletion or post-transplant cyclophosphamide in children with advanced B-cell neoplasms

Larisa Shelikhova, Olga Molostova, Ekaterina Malakhova, Rimma Khismatullina, Maria Klimentova, Yakov Muzalevsky, Aleksey Kazachenok, Dmitriy Pershin, Maria Fadeeva, Alexander Popov, Natalia Myakova, Galina Novichkova, Alexey Maschan, Michael Maschan

Blood (2025) 146 (Supplement 1): 5939.

https://doi.org/10.1182/blood-2025-5939

Published: 2025

Journal Articles

Donor-Derived CAR-T Cells in Children with B-Lineage Acute Lymphoblastic Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: Report of 20 Cases

Blood (2024) 144 (Supplement 1): 7218.

https://doi.org/10.1182/blood-2024-205696

Published: 2024

Journal Articles

Venetoclax after Progression on Ibrutinib: Results of a Russian Multicenter Study

Blood (2023) 142 (Supplement 1): 6547.

https://doi.org/10.1182/blood-2023-184671

Published: 2023

Journal Articles

Post-Transplant Cyclophosphamide, Abatacept, and Vedolizumab to Prevent Graft-Versus-Host Disease after Hematopoietic Stem Cells Transplantation from Haploidentical Donors in Children with Acute Leukemia: Results of a Prospective Trial

Larisa Shelikhova, Margarita Perminova, Olga Molostova, Maria Ilushina, Rimma Khismatullina, Dmitriy Balashov, Natalia Miakova, Julia Skvortsova, Maria Dunaikina, Svetlana Radygina, Galina Novichkova, Svetlana Kozlovskaya, Sergei Blagov, Elena Kurnikova, Anna Livshits, Dmitriy Pershin, Dmitriy Litvinov, Alexey Maschan, Michael Maschan

Blood (2023) 142 (Supplement 1): 3555.

https://doi.org/10.1182/blood-2023-182895

Published: 2023

Journal Articles

Allogeneic Donor-Derived Myeloid Antigen Directed CAR-T Cells - for Relapsed/Refractory Acute Myeloid Leukemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: Report of Three Cases

Larisa Shelikhova, Arina Rakhteenko, Olga Molostova, Elena Kurnikova, V. Ukrainskaya, Yakov Muzalevsky, Dmitry Pershin, Alexander Popov, Elena Kulakovskaya, Dina Baidildina, Alexey Stepanov, Elena Osipova, Galina Novichkova, Alexey Maschan, Michael Maschan

Blood (2022) 140 (Supplement 1): 4600–4601.

https://doi.org/10.1182/blood-2022-168891

Published: 2022

Journal Articles

Tcrαβ+/CD19+-Depletion in Hematopoietic Stem Cells Transplantation from Matched Unrelated and Haploidentical Donors in Pediatric Acute Lymphoblastic Leukemia Patients in Complete Remission

Larisa Shelikhova, Rimma Khismatullina, Dmitriy Balashov, Alexey Kazachenok, Yakov Muzalevsky, Julia Abugova, Julia Skvortsova, Alexander Popov, Dmitry Pershin, Daria Kobyzeva, Alexey Nechesnyuk, Yulia Olshanskaya, Svetlana Kozlovskaya, Sergey Blagov, Natalia Miakova, Galina Novichkova, Alexey Maschan, Michael Maschan

Blood (2022) 140 (Supplement 1): 2113–2114.

https://doi.org/10.1182/blood-2022-168605

Published: 2022

Journal Articles

Results of Hematopoietic Stem Cells Transplantation with Tcrαβ and CD19-Depletion from Matched Related Donors and Infusions of CD45RA Depleted Donor Lymphocytes in Pediatric Severe Aplastic Anemia

Blood (2021) 138 (Supplement 1): 558.

https://doi.org/10.1182/blood-2021-152769

Published: 2021

Journal Articles

CD19 CAR-T Cell Therapy in Children with Relapsed and Refractory B-ALL

Olga Molostova, Larisa Shelikhova, Yakov Muzalevsky, Alexey Kazachenok, Rimma Khismatullina, Julia Abugova, Elena Kurnikova, Pavel Trakhtman, Dmitry Pershin, Viktoria Zubachenko, Maria Fadeeva, Alexander M Popov, Olga Illarionova, Natalia Miakova, Dmitry Litvinov, Galina Novichkova, Alexey Maschan, Michael Maschan

Blood (2021) 138 (Supplement 1): 1737.

https://doi.org/10.1182/blood-2021-153414

Published: 2021

Journal Articles

Haploidentical Donor-Derived CAR-T Cells Are Safely and Effectively Co-Infused with the Haploidentical Graft, Depleted of Ab T Cells: Report of Case Series

Larisa Shelikhova, Olga Molostova, Arina Rakhteenko, Rimma Khismatullina, Julia Abugova, Elena Kurnikova, Yakov Muzalevsky, Alexey Kazachenok, Dmitry Pershin, Maria Fadeeva, Alexander M Popov, Olga Illarionova, Natalia Miakova, Dmitry Litvinov, Galina Novichkova, Alexey Maschan, Michael Maschan

Blood (2021) 138 (Supplement 1): 1736.

https://doi.org/10.1182/blood-2021-153343

Published: 2021

Journal Articles

Safety and Efficacy of CD19 CAR T-Cells for Pediatric Relapsed Acute Lymphoblastic Leukemia with Active CNS Involvement

Elad Jacoby, MD, Sara Ghorashian, FRCPath, PhD, Britta Julia Vormoor, MD, Barbara De Moerloose, MD, Nicole Bodmer, Michael Maschan, MD, Asaf David Yanir, MD, Bella Bielorai, MD, Srdan Rogosic, Olga Molostova, MD, Claudia Rossig, Amos Toren, MD PhD, Arend von Stackelberg, MD, Jean-Pierre Bourquin, MD PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-141940

Published: 2020

Journal Articles

CAR-T Therapy for Lymphoma with Prophylactic Tocilizumab: Decreased Rates of Severe Cytokine Release Syndrome without Excessive Neurologic Toxicity

Paolo F Caimi, MD, Ashish Sharma, Patricio Rojas, MD, Seema Patel, PharmD, Jane Reese, Folashade Otegbeye, MBBChir,MPH, Andrew Worden, Michael Kadan, Michael Maschan, MD PhD, Rimas J Orentas, PhD, Boro Dropulic, PhDMBA, Rafick Sekaly, Marcos de Lima, MD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-143114

Published: 2020

Journal Articles

Total Body Irradiation Among Recipients of Tcrαβ /CD19- Depleted Grafts in a Cohort of Children with Hematologic Malignances: Single Center Experience

Daria Kobyzeva, MD, Larisa Shelikhova, PhD, Zhanna Shekhovtsova, MD, Rimma Khismatullina, MD, Maria Ilushina, MD, Anna Loginova, Alexey Nechesnuyk, PhD, Michael Maschan, PhDMSc

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-139282

Published: 2020

Journal Articles

Infant Acute Myeloid Leukemia with t(X;6)(p11;q23)/ MYB-GATA1 - a First Female Case in the Entity

Elena Zerkalenkova, PhD, Ludmila Zemtsova, Aleksandra Borkovskaya, Marina Gaskova, Marat Kazanov, Michael Maschan, MD, Alexey Maschan, MD, Galina Novichkova, MD, Yulia Olshanskaya, MD PhD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-140218

Published: 2020

Journal Articles

Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies

Alexandra Laberko, Elvira Sultanova, Elena Gutovskaya, Irina Shipitsina, Larisa Shelikhova, Elena Kurnikova, Yakov Muzalevskii, Alexei Kazachenok, Dmitriy Pershin, Kirill Voronin, Anna Shcherbina, Michael Maschan, Alexey Maschan, Dmitry Balashov

Blood (2019) 134 (20): 1755–1763.

https://doi.org/10.1182/blood.2019001757

Published: 2019

Includes: Supplemental data

Journal Articles

Novel KMT2A Partner Gene NUTM2A Revealed By Anchored Multiplex PCR in ALL

Svetlana Lebedeva, Elena Zerkalenkova, PhD, Olga Soldatkina, Michael Maschan, MD PhD, Alexey A. Maschan, MD, Galina Novichkova, MD PhD, Yulia Olshanskaya, MD PhD

Blood (2019) 134 (Supplement_1): 5203.

https://doi.org/10.1182/blood-2019-126602

Published: 2019

Journal Articles

Local Manufacture of CD19 CAR-T Cells Using an Automated Closed-System: Robust Manufacturing and High Clinical Efficacy with Low Toxicities

Blood (2019) 134 (Supplement_1): 2625.

https://doi.org/10.1182/blood-2019-130370

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Comparison of outcomes in pediatric patients with acute leukemia undergoing allogeneic HLA-haploidentical hematopoietic stem cell transplantation (HSCT) after in vitro a/b T- and CD19-cell depletion or In Vivo administration of post-transplant cyclophosphamide: An EBMT pediatric working party study

Haploidentical donor regulatory T cells and memory T cells are safe and effective in children with refractory graft-versus-host disease with concurrent viral infections

Significance of CD229 expression assessment for detection of minimal residual disease in patients with multiple myeloma.

Targeted GvHD prophylaxis: Vedolizumab in the GvHD prevention regime with post-transplant cyclophophospamide, abatacept, calceneurin inhibitors in adults with hematologic disease: Result prospective study

Donor-derived CAR-T cells co-infused with the allogenic graft on the platform of T cell depletion or post-transplant cyclophosphamide in children with advanced B-cell neoplasms

Donor-Derived CAR-T Cells in Children with B-Lineage Acute Lymphoblastic Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: Report of 20 Cases

Venetoclax after Progression on Ibrutinib: Results of a Russian Multicenter Study

Post-Transplant Cyclophosphamide, Abatacept, and Vedolizumab to Prevent Graft-Versus-Host Disease after Hematopoietic Stem Cells Transplantation from Haploidentical Donors in Children with Acute Leukemia: Results of a Prospective Trial

Allogeneic Donor-Derived Myeloid Antigen Directed CAR-T Cells - for Relapsed/Refractory Acute Myeloid Leukemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: Report of Three Cases

Tcrαβ+/CD19+-Depletion in Hematopoietic Stem Cells Transplantation from Matched Unrelated and Haploidentical Donors in Pediatric Acute Lymphoblastic Leukemia Patients in Complete Remission

Results of Hematopoietic Stem Cells Transplantation with Tcrαβ and CD19-Depletion from Matched Related Donors and Infusions of CD45RA Depleted Donor Lymphocytes in Pediatric Severe Aplastic Anemia

CD19 CAR-T Cell Therapy in Children with Relapsed and Refractory B-ALL

Haploidentical Donor-Derived CAR-T Cells Are Safely and Effectively Co-Infused with the Haploidentical Graft, Depleted of Ab T Cells: Report of Case Series

Safety and Efficacy of CD19 CAR T-Cells for Pediatric Relapsed Acute Lymphoblastic Leukemia with Active CNS Involvement

CAR-T Therapy for Lymphoma with Prophylactic Tocilizumab: Decreased Rates of Severe Cytokine Release Syndrome without Excessive Neurologic Toxicity

Total Body Irradiation Among Recipients of Tcrαβ /CD19- Depleted Grafts in a Cohort of Children with Hematologic Malignances: Single Center Experience

Infant Acute Myeloid Leukemia with t(X;6)(p11;q23)/ MYB-GATA1 - a First Female Case in the Entity

Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies

Novel KMT2A Partner Gene NUTM2A Revealed By Anchored Multiplex PCR in ALL

Local Manufacture of CD19 CAR-T Cells Using an Automated Closed-System: Robust Manufacturing and High Clinical Efficacy with Low Toxicities

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only